2023
DOI: 10.1158/1078-0432.22477938.v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Supplementary Data from Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results from the Phase II SOLTI-1303 PATRICIA Trial

Abstract: <p>Supplementary Data</p>

Help me understand this report
View published versions

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles